Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer

episode

Breast Cancer Update not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Hog Heaven, MAGA Hell 52 min · 24 Sep 2026 · I've Had It

KFC and Gen Z, OAPs and ChatGPT & An Email to Jimmy Fallon. 34 min · 24 Sep 2026 · Ray D'Arcy Daily

Bonds, Stocks Drop as Yields Extend Rally 2 min · 24 Sep 2026 · WSJ Minute Briefing

Judge gives press a pass 4 min · 24 Sep 2026 · Wall Street Breakfast

Court Temporarily Blocks Media Ban, Trump-Xi White House Meeting, UNGA Diplomacy 15 min · 24 Sep 2026 · Up First from NPR

6AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded13 Jun 2024

Publisherfeeds.captivate.fm ↗

Handlerec:5010180

Show notes

Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and practical considerations with ovarian function suppression for hormone receptor-positive breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in